Dessika Rahmawati

Dessika Rahmawati

Auto-generated profile, based on publicly available information

Dessika Rahmawati

Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2026 in Sleep Medicine Research
Verified
Journal Article
Open access
PDF file
DRDessika Rahmawati
Dessika Rahmawati
MBM. Biomed
M. Biomed
DRDwita Sukmala Ratih
Dwita Sukmala Ratih
SKShahdevi Nandar Kurniawan
Shahdevi Nandar Kurniawan
SASri Andarini
Sri Andarini
Background and Objective Dexamethasone is a corticosteroid commonly used in patients with brain tumors to manage vasogenic edema and intracranial pressure. However, it is often associated with sleep disturbances that can impair patients’ quality of life. This study aimed to evaluate the relationship between dexamethasone therapy and sleep disorders using the Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI), and serum melatonin levels in patients with brain tumors.Methods A cross-sectional study was conducted involving 66 patients with brain tumors at Saiful Anwar General Hospital, Malang. Subjects were divided into two groups: dexamethasone users and non-users. Sleep quality was assessed using PSQI and ISI, while melatonin levels were analyzed from blood samples drawn during daytime (11:00–12:00 am).Results The dexamethasone group had significantly higher PSQI (p=0.006) and ISI (p<0.001) scores, indicating worse sleep quality and greater insomnia severity compared to non-users. However, there was no significant association between melatonin levels and dexamethasone use (p=0.131).Conclusions Dexamethasone therapy is associated with impaired sleep quality and increased insomnia severity in brain tumor patients. However, no significant correlation was found between melatonin levels and sleep disturbances. The daytime sampling of melatonin may have limited the hormonal assessment. Further studies with nocturnal sampling are recommended.

20 May 2026 in MNJ (Malang Neurology Journal)
Verified
Journal Article
Open access
PDF file
FIFatma Rahmalia Izzati
Fatma Rahmalia Izzati
EAEko Arisetijono
Eko Arisetijono
DRDessika Rahmawati
Dessika Rahmawati
THTita Hariyanti
Tita Hariyanti
Background: Stroke is the third leading cause of death globally, and early prediction of in-hospital mortality risk is essential for improving clinical outcomes and optimizing resource allocation. However, no in-hospital mortality system applicable to both ischemic and hemorrhagic stroke currently exists in Indonesia. This study aims to identify significant predictors of in-hospital mortality among stroke patients, to develop an in-hospital mortality prediction score system, and to assess the performance of the score. Methods: This retrospective cohort study included stroke patients hospitalized at Dr. Saiful Anwar Hospital, Malang, Indonesia in January-December 2024, with data obtained from electronic medical records. Multivariate logistic regression with backward stepwise elimination was performed to identify predictors significantly associated with in-hospital mortality. Scoring weights were derived from regression coefficients. Model performance was assessed using accuracy, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and the area under the curve (AUC). Results: Eight significant predictors were identified: age ≥60 years, male sex, National Institute of Health Stroke Scale (NIHSS) ≥16, leukocytosis, hyperglycemia, hemorrhagic stroke type, pneumonia, and sepsis. These predictors were incorporated into an in-hospital mortality scoring system. The scoring system demonstrated an accuracy of 72.92%, sensitivity 80%, specificity 71.77%, PPV 31.37%, NPV 95.7%, and an AUC of 0.784. Conclusions: Eight out of thirteen proposed predictors were significantly associated with in-hospital mortality among stroke patients. Based on these predictors, a prognostic scoring system for in-hospital mortality was developed, demonstrating fair discriminative performance.